Pregabalin Capsule 75 mg (Pregabalin)

Adult dose

This drug is administered orally in divided doses twice daily without regard to meals. 1. Neuropathic Pain - Peripheral Neuropathic Pain: Start with a dosage of 150 mg per day, which may be increased to 300 mg per day after 3-7 days, and if needed, may be further increased to a maximum of 600 mg with a 7-day interval. - Central Neuropathic Pain: Start with a dosage of 150 mg per day, which may be increased to 300 mg per day after one week.

Child dose

Use in children under 12 years of age and in adolescents aged 12-17 years is not recommended.

This drug may increase the risk of suicidal thoughts or behaviors, so patients should immediately inform healthcare providers if they experience mood changes or depression symptoms during treatment. It should not be administered to patients with hypersensitivity to this drug or specific genetic metabolic disorders. Diabetic patients may experience weight gain while taking this drug, which may require adjustments in their blood sugar control medications. If symptoms of angioedema occur, use should be discontinued immediately, and elderly patients should be cautious of the risk of falls due to dizziness or drowsiness. This drug may cause blurred vision or changes in eyesight, so any abnormal symptoms should be discussed with healthcare providers. Abrupt discontinuation of this drug can result in withdrawal symptoms such as insomnia, headache, nausea, and anxiety, so it should be gradually tapered under medical supervision. Patients with a history of drug abuse should use this drug cautiously due to the potential for misuse or dependence and should report any unusual behavior to healthcare providers. Patients with reduced renal function may require dose adjustments, and those with cardiovascular diseases should take caution. There is an increased risk of respiratory depression when taken in combination with other medications that have central nervous system depressant effects, so caution is needed during concurrent use. This drug should not be administered to pregnant women during early pregnancy due to the risk of fetal malformations unless in special cases, and women of childbearing age should use effective contraception. Breastfeeding women should consider discontinuing either breastfeeding or medication as this drug may pass into breast milk and affect infants. Dizziness and drowsiness are common side effects; thus, it is advisable to avoid driving or operating hazardous machinery after taking this drug. In case of overdose, confusion, drowsiness, depression, seizures, etc., may occur, requiring immediate medical attention.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), profound lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urinary issues.

Mild side effects

• Dizziness
• drowsiness
• confusion
• disturbed orientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This drug should be stored in a tightly closed container to prevent exposure to air or moisture. The storage temperature should be maintained between 15 to 30 degrees Celsius.

Appearance

A hard capsule with an upper reddish-brown part and a lower white part containing white powder that is white or light yellow.

Package unit

30 capsules/bottle, 100 capsules/bottle